Patient reported outcomes in GNE myopathy: incorporating a valid assessment of physical function in a rare disease

References

• Huizing M, Malicdan MV, Krasnewich DM, et al. GNE myopathy. In: Scriver CR, Childs B, Sly WS, Valle D, Beaudet AL, Vogelstein B, Kinsler KW, editors. Scriver's online metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2014. Available from: http://www.ommbid.com
   Google Scholar
• Huizing M, Carrillo-Carrasco N, Malicdan MC, et al. GNE myopathy: new name and new mutation nomenclature. Neuromuscul Disord. 2014;24:387–389.
   PubMed Web of Science ®Google Scholar
• Nishino I, Carrillo-Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatry. 2015;86:385–392.
   PubMed Web of Science ®Google Scholar
• Eisenberg I, Avidan N, Potikha T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet. 2001;29:83–87.
   PubMed Web of Science ®Google Scholar
• Celeste FV, Vilboux T, Ciccone C, et al. Mutation update for GNE gene variants associated with GNE myopathy. Hum Mutat. 2014;35:915–926.
   PubMed Web of Science ®Google Scholar
• Argov Z, Yarom R. Rimmed vacuole myopathy sparing the quadriceps. A unique disorder in Iranian Jews. J Neurol Sci. 1984;64:33–43.
   PubMed Web of Science ®Google Scholar
• Nishino I, Carrillo-Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatr. 2015;86:385–392.
   PubMed Web of Science ®Google Scholar
• Bennell K, Dobson F, Hinman R. Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task. Arthritis Care Res. 2011;63(Suppl 11):S350–S370.
   Google Scholar
• Merlini L, Sabatelli P. Improving clinical trial design for Duchenne muscular dystrophy. BMC Neurol. 2015;15:153.
   PubMed Web of Science ®Google Scholar
• Hoffman EP, Connor EM. Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. Discov Med. 2013;16:233–239.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Ferrans Ce Fau - Halyard MY, Halyard My Fau - Revicki DA, et al. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc. 2007;82:1229–1239.
   Google Scholar
• McLeod LD, Coon CD, Martin SA, et al. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11:163–169.
   PubMed Web of Science ®Google Scholar
• FDA. Guidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims. Silver Spring, MD; 2009.
   Google Scholar
• FDA. Duchenne muscular dystrophy and related dystrophinopathies: developing drugs for treatment: draft guidance for industry. Rockville, MD; June 2015.
   Google Scholar
• FDA. Rare diseases: common issues in drug development: draft guidance for industry. Rockville, MD; 2015.
   Google Scholar
• Davidson M, de Morton N. A systematic review of the Human Activity Profile. Clin Rehabil. 2007;21:151–162.
   PubMed Web of Science ®Google Scholar
• Daughton DM, Fix AJ, Kass I, et al. Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil. 1982;63:620–622.
   PubMed Web of Science ®Google Scholar
• Anand S, Chertow GM, Johansen KL, et al. Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study. J Ren Nutr. 2011;21:429–437.
   PubMed Web of Science ®Google Scholar
• Brouwer B, Musselman K, Culham E. Physical function and health status among seniors with and without a fear of falling. Gerontology. 2004;50:135–141.
   PubMed Web of Science ®Google Scholar
• Herzberg PY, Heussner P, Mumm FH, et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010;16:1707–1717.
   PubMed Web of Science ®Google Scholar
• Fix AJ, Daughton DM. Human Activity Profile professional manual. Lutz (FL): Psychological Assessment Resources; 1998.
   Google Scholar
• Amato AA, Barohn RJ. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatr. 2009;80:1186–1193.
   PubMed Web of Science ®Google Scholar
• Jackson CE, Barohn RJ, Gronseth G, et al. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve. 2008;37:473–476.
   PubMed Web of Science ®Google Scholar
• Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S118–S157.
   PubMed Web of Science ®Google Scholar
• Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) scale. J Gerontol A Biol Sci Med Sci. 1995;50A:M28–M34.
   PubMed Web of Science ®Google Scholar
• Lajoie Y, Gallagher SP. Predicting falls within the elderly community: comparison of postural sway, reaction time, the Berg balance scale and the Activities-specific Balance Confidence (ABC) scale for comparing fallers and non-fallers. Arch Gerontol Geriatr. 2004;38:11–26.
   PubMed Web of Science ®Google Scholar
• Ganesan M, Kanekar N, Aruin AS. Direction-specific impairments of limits of stability in individuals with multiple sclerosis. Ann Phys Rehabil Med. 2015;58:145–150.
   PubMed Web of Science ®Google Scholar
• Myers AM, Fletcher PC, Myers AH, et al. Discriminative and evaluative properties of the activities-specific balance confidence (ABC) scale. J Gerontol A Biol Sci Med Sci. 1998;53:M287–M294.
   PubMed Web of Science ®Google Scholar
• Harris-Love MO, Joe G, Davenport TE, et al. Reliability of the adult myopathy assessment tool in individuals with myositis. Arthritis Care Res (Hoboken). 2015;67:563–570.
   PubMed Web of Science ®Google Scholar
• Harris-Love MO, Fernandez-Rhodes L, Joe G, et al. Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool. Rehabil Res Pract. 2014;2014:873872.
   PubMedGoogle Scholar
• Shrader JA, Kats I, Kokkinis A, et al. A randomized controlled trial of exercise in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol. 2015;2:739–747.
   PubMed Web of Science ®Google Scholar
• Visser J, Mans E, de Visser M, et al. Comparison of maximal voluntary isometric contraction and hand-held dynamometry in measuring muscle strength of patients with progressive lower motor neuron syndrome. Neuromuscul Disord. 2003;13:744–750.
   PubMed Web of Science ®Google Scholar
• Andres PL, Hedlund W, Finison L, et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology. 1986;36:937–941.
   PubMed Web of Science ®Google Scholar
• Brussock CM, Haley SM, Munsat TL, et al. Measurement of isometric force in children with and without Duchenne's muscular dystrophy. Phys Ther. 1992;72:105–114.
   PubMed Web of Science ®Google Scholar
• NIMS. Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium. Arch Phys Med Rehabil. 1996;77:1251–1255.
   PubMed Web of Science ®Google Scholar
• Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther 1996;76:248–259.
   PubMed Web of Science ®Google Scholar
• Duncan PW, Weiner DK, Chandler J, et al. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45:M192–M197.
   PubMedGoogle Scholar
• Behrman AL, Light KE, Flynn SM, et al. Is the functional reach test useful for identifying falls risk among individuals with Parkinson's disease? Arch Phys Med Rehabil. 2002;83:538–542.
   PubMed Web of Science ®Google Scholar
• Duncan PW, Studenski S, Chandler J, et al. Functional reach: predictive validity in a sample of elderly male veterans. J Gerontol. 1992;47:M93–M98.
   PubMedGoogle Scholar
• Maranesi E, Ghetti G, Rabini RA, et al. Functional reach test: movement strategies in diabetic subjects. Gait Posture. 2014;39:501–505.
   PubMed Web of Science ®Google Scholar
• Lynch SM, Leahy P, Barker SP. Reliability of measurements obtained with a modified functional reach test in subjects with spinal cord injury. Phys Ther. 1998;78:128–133.
   PubMed Web of Science ®Google Scholar
• Weiner DK, Duncan PW, Chandler J, et al. Functional reach: a marker of physical frailty. J Am Geriatr Soc. 1992;40:203–207.
   PubMed Web of Science ®Google Scholar
• Hasmann SE, Berg D, Hobert MA, et al. Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls. Front Aging Neurosci. 2014;6:286.
   PubMed Web of Science ®Google Scholar
• Casanova C, Celli BR, Barria P, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 2011;37:150–156.
   PubMed Web of Science ®Google Scholar
• Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155:1278–1282.
   PubMed Web of Science ®Google Scholar
• Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD. 2005;2:125–129.
   PubMedGoogle Scholar
• Lu QL, Cirak S, Partridge T. What can we learn from clinical trials of exon skipping for DMD? Mol Ther Nucleic Acids. 2014;3:e152.
   PubMedGoogle Scholar
• Mokkink LB, Prinsen CA, Bouter LM, et al. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument. Braz J Phys Ther. 2016;20:105–113.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–1160.
   PubMed Web of Science ®Google Scholar
• Stuifbergen AK. Physical activity and perceived health status in persons with multiple sclerosis. J Neurosci Nurs. 1997;29:238–243.
   PubMedGoogle Scholar
• Bilek LD, Venema DM, Camp KL, et al. Evaluation of the human activity profile for use with persons with arthritis. Arthritis Rheum. 2005;53:756–763.
   PubMed Web of Science ®Google Scholar
• Johansen KL, Painter P, Kent-Braun JA, et al. Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. Kidney Int. 2001;59:1121–1127.
   PubMed Web of Science ®Google Scholar
• Farrell MJ, Gibson SJ, Helme RD. Measuring the activity of older people with chronic pain. Clin J Pain. 1996;12:6–12.
   PubMed Web of Science ®Google Scholar
• Mori-Yoshimura M, Oya Y, Yajima H, et al. GNE myopathy: a prospective natural history study of disease progression. Neuromuscul Disord. 2014;24:380–386.
   PubMed Web of Science ®Google Scholar
• Mori-Yoshimura M, Hayashi YK, Yonemoto N, et al. Nationwide patient registry for GNE myopathy in Japan. Orphanet J Rare Dis. 2014;9:150.
   PubMed Web of Science ®Google Scholar
• Mori-Yoshimura M, Monma K, Suzuki N, et al. Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations. J Neurol Sci. 2012;318:100–105.
   PubMed Web of Science ®Google Scholar
• Mori-Yoshimura M, Oya Y, Hayashi YK, et al. Respiratory dysfunction in patients severely affected by GNE myopathy (distal myopathy with rimmed vacuoles). Neuromuscul Disord. 2013;23:84–88.
   PubMed Web of Science ®Google Scholar
• Argov Z, Eisenberg I, Grabov-Nardini G, et al. Hereditary inclusion body myopathy: the Middle Eastern genetic cluster. Neurology. 2003;60:1519–1523.
   PubMed Web of Science ®Google Scholar
• Broccolini A, Pescatori M, D'Amico A, et al. An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene. Neurology. 2002;59:1808–1809.
   PubMed Web of Science ®Google Scholar
• Chaouch A, Brennan KM, Hudson J, et al. Two recurrent mutations are associated with GNE myopathy in the North of Britain. J Neurol Neurosurg Psychiatry 2014;85:1359–1365.
   PubMed Web of Science ®Google Scholar
• Botner EM, Miller WC, Eng JJ. Measurement properties of the Activities-specific Balance Confidence Scale among individuals with stroke. Disabil Rehabil. 2005;27:156–163.
   PubMed Web of Science ®Google Scholar
• Talley KM, Wyman JF, Gross CR. Psychometric properties of the activities-specific balance confidence scale and the survey of activities and fear of falling in older women. J Am Geriatr Soc. 2008;56:328–333.
   PubMed Web of Science ®Google Scholar